Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietic protoporphyria

T M Cox1

  • 1Department of Medicine, University of Cambridge, Addenbrooke's Hospital, UK.

Journal of Inherited Metabolic Disease
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Erythropoietic protoporphyria, a condition of partial ferrochelatase deficiency, causes photosensitivity due to protoporphyrin buildup. Advances in enzyme assays and gene cloning may predict disease transmission and clinical outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune signatures underlying post-acute COVID-19 lung sequelae.

Science immunology·2021
Same author

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.

Blood cells, molecules & diseases·2017
Same author

Orphan drugs: expensive yet necessary.

QJM : monthly journal of the Association of Physicians·2015
Same author

Orphan drugs: expensive yet necessary.

QJM : monthly journal of the Association of Physicians·2014
Same author

On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritis.

Journal of anatomy·2014
Same author

Limits on use of health economic assessments for rare diseases.

QJM : monthly journal of the Association of Physicians·2014
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Dermatology

Background:

  • Partial deficiency of ferrochelatase, the final enzyme in heme biosynthesis, results in protoporphyrin overproduction.
  • This overproduction by erythropoietic tissue leads to a distinct syndrome of photosensitivity.
  • Erythropoietic protoporphyria exhibits an indeterminate inheritance pattern and can lead to severe liver disease.

Purpose of the Study:

  • To review the pathological features, genetics, and treatment of erythropoietic protoporphyria.
  • To highlight recent advancements in understanding the disorder's transmission and clinical prediction.

Main Methods:

  • Review of existing literature on porphyria, focusing on erythropoietic protoporphyria.
  • Discussion of recent developments in ferrochelatase enzyme assays.

Related Experiment Videos

  • Examination of the implications of human ferrochelatase gene cloning.

    • Main Results:

    • Ferrochelatase deficiency causes photosensitivity and potential liver complications.
    • New assays and gene cloning offer insights into inheritance and disease prediction.
    • The review covers pathology, genetics, and therapeutic strategies.

    Conclusions:

    • Understanding ferrochelatase deficiency is key to managing erythropoietic protoporphyria.
    • Recent molecular and biochemical advances are crucial for predicting disease course.
    • Comprehensive management involves addressing pathological, genetic, and treatment aspects.